Landmark World Trade Organization Ruling On Plain Tobacco Packaging Hailed As “Public Health Victory” By WHO 10/06/2020 Grace Ren In what he described as a great “public health victory,” the World Trade Organization has ruled that Australia’s plain packaging requirements for tobacco products did not infringe on international trade, said the World Health Organization Director-General Dr Tedros Adhanom Ghebreyesus on Wednesday. The decision by the WTO on Tuesday comes just as it also opened […] Continue reading -> WHO Member States Near Accord On Resolution For COVID-19 Response; Advocacy Groups Ask – Will It Have Teeth….Or Not? 13/05/2020 Elaine Ruth Fletcher World Health Organization member states were close to an agreement Wednesday evening on a European Union-led draft resolution on global COVID-19 response to the upcoming World Health Assembly. If approved, it would pave the way for coordinated planning by the global health community to ensure wide and equitable access by people worldwide to COVID-19 medicines […] Continue reading -> World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> World Trade Organization Cancels Meetings At Geneva Headquarters Following COVID-19 Case; WHO Ramps Up Safety Measures 10/03/2020 Elaine Ruth Fletcher The World Trade Organization’s director general Roberto Azevêdo announced on Tuesday that he was suspending all WTO meetings at its Geneva offices, following the confirmation of a COVID-19 case among staff. It was the first publicly-announced case of the novel coronavirus infection at a Geneva-based United Nations or UN-affiliated organization since the epidemic began, which […] Continue reading -> Challenges & Opportunities Of Cutting-Edge Health Technologies Discussed At WTO-WHO-WIPO Symposium 31/10/2019 Grace Ren Cutting-edge health technologies – such as gene editing therapies for cancer – have the potential to save lives, and the international intellectual property system should be leveraged to drive innovation and bring those therapies to people who need them, said the leaders of global health, trade and intellectual property agencies at a Trilateral Symposium on […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa 18/06/2018 Patralekha Chatterjee Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture. Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Member States Near Accord On Resolution For COVID-19 Response; Advocacy Groups Ask – Will It Have Teeth….Or Not? 13/05/2020 Elaine Ruth Fletcher World Health Organization member states were close to an agreement Wednesday evening on a European Union-led draft resolution on global COVID-19 response to the upcoming World Health Assembly. If approved, it would pave the way for coordinated planning by the global health community to ensure wide and equitable access by people worldwide to COVID-19 medicines […] Continue reading -> World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> World Trade Organization Cancels Meetings At Geneva Headquarters Following COVID-19 Case; WHO Ramps Up Safety Measures 10/03/2020 Elaine Ruth Fletcher The World Trade Organization’s director general Roberto Azevêdo announced on Tuesday that he was suspending all WTO meetings at its Geneva offices, following the confirmation of a COVID-19 case among staff. It was the first publicly-announced case of the novel coronavirus infection at a Geneva-based United Nations or UN-affiliated organization since the epidemic began, which […] Continue reading -> Challenges & Opportunities Of Cutting-Edge Health Technologies Discussed At WTO-WHO-WIPO Symposium 31/10/2019 Grace Ren Cutting-edge health technologies – such as gene editing therapies for cancer – have the potential to save lives, and the international intellectual property system should be leveraged to drive innovation and bring those therapies to people who need them, said the leaders of global health, trade and intellectual property agencies at a Trilateral Symposium on […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa 18/06/2018 Patralekha Chatterjee Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture. Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Health Assembly Resolution On COVID-19 Response: The Stark Choices Faced In A Polarized World Of Global Health 08/05/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher As the 73rd World Health Assembly approaches, the European Union-sponsored draft resolution on the COVID-19 response is gathering steam and storm as it rolls closer to the planned opening of the Assembly on 18 May – with far less clarity about how it might actually hit the shores of the public debate. The resolution aims […] Continue reading -> World Trade Organization Cancels Meetings At Geneva Headquarters Following COVID-19 Case; WHO Ramps Up Safety Measures 10/03/2020 Elaine Ruth Fletcher The World Trade Organization’s director general Roberto Azevêdo announced on Tuesday that he was suspending all WTO meetings at its Geneva offices, following the confirmation of a COVID-19 case among staff. It was the first publicly-announced case of the novel coronavirus infection at a Geneva-based United Nations or UN-affiliated organization since the epidemic began, which […] Continue reading -> Challenges & Opportunities Of Cutting-Edge Health Technologies Discussed At WTO-WHO-WIPO Symposium 31/10/2019 Grace Ren Cutting-edge health technologies – such as gene editing therapies for cancer – have the potential to save lives, and the international intellectual property system should be leveraged to drive innovation and bring those therapies to people who need them, said the leaders of global health, trade and intellectual property agencies at a Trilateral Symposium on […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa 18/06/2018 Patralekha Chatterjee Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture. Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Trade Organization Cancels Meetings At Geneva Headquarters Following COVID-19 Case; WHO Ramps Up Safety Measures 10/03/2020 Elaine Ruth Fletcher The World Trade Organization’s director general Roberto Azevêdo announced on Tuesday that he was suspending all WTO meetings at its Geneva offices, following the confirmation of a COVID-19 case among staff. It was the first publicly-announced case of the novel coronavirus infection at a Geneva-based United Nations or UN-affiliated organization since the epidemic began, which […] Continue reading -> Challenges & Opportunities Of Cutting-Edge Health Technologies Discussed At WTO-WHO-WIPO Symposium 31/10/2019 Grace Ren Cutting-edge health technologies – such as gene editing therapies for cancer – have the potential to save lives, and the international intellectual property system should be leveraged to drive innovation and bring those therapies to people who need them, said the leaders of global health, trade and intellectual property agencies at a Trilateral Symposium on […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa 18/06/2018 Patralekha Chatterjee Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture. Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Challenges & Opportunities Of Cutting-Edge Health Technologies Discussed At WTO-WHO-WIPO Symposium 31/10/2019 Grace Ren Cutting-edge health technologies – such as gene editing therapies for cancer – have the potential to save lives, and the international intellectual property system should be leveraged to drive innovation and bring those therapies to people who need them, said the leaders of global health, trade and intellectual property agencies at a Trilateral Symposium on […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa 18/06/2018 Patralekha Chatterjee Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture. Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa 18/06/2018 Patralekha Chatterjee Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture. Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EU Disputes New Turkish Rules Requiring Pharma To Produce Drugs Locally 08/04/2019 David Branigan The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa 18/06/2018 Patralekha Chatterjee Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture. Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa 18/06/2018 Patralekha Chatterjee Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture. Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa 18/06/2018 Patralekha Chatterjee Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture. Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading -> The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The Myth Behind Health And Trade Agreements: Q&A With Othoman Mellouk 15/06/2018 Patralekha Chatterjee Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. Continue reading -> Posts navigation Older postsNewer posts